search for
or search by
Results 1 - 20 of 373
Genisphere Begins Collaborative & Sponsored Research Program With the University of Maryland
Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia Muro.
Pharmatek Adds Further cGMP Spray Drying Capacity in Response to Demand for Improved Pharmaceutical Solubility
Catalent Pharma Solutions recently announced that it is increasing spray drying capacity at its Pharmatek, San Diego, CA, facility with the installation of an additional GEA Niro Mobile Minor unit.
Q BioMed Announces Licensing Agreement
Q BioMed Inc. and ASDERA LLC recently announced a licensing agreement that provides Q BioMed with the worldwide exclusive rights to ASDERA's ASD-002, which is being developed to treat a rare pediatric nonverbal disorder. Under the terms of the agreement, Q Biomed receives global rights to develop and commercialize the drug in the rare pediatric disease market.
SteadyMed Raises $30 Million
SteadyMed Ltd., a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral delivery needs, today announced that it has entered into a definitive agreement to sell its ordinary shares and warrants to purchase its ordinary shares for aggregate gross proceeds of approximately $30 million in a private placement.
Crown Bioscience Launches e-Commerce Platform to Commercialize its Life Science Products
Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has launched an e-commerce platform to support the commercialization of its Life Science products.
Pipeline Drug Offers Promise in Treatment of Platinum-Resistant Ovarian Cancer
Mirvetuximab soravtansine, a drug currently being trialed by ImmunoGen, has the potential to solve a major unmet medical need for patients with platinum-resistant ovarian cancer, according to research and consulting firm GlobalData.
New Glatt GPCG 10 Fluid Bed Granulator at Metrics
Enhancing its known expertise in developing multi-particulate and modified-release drug products, Metrics Contract Services has acquired a new Glatt GPCG 10 fluid bed granulator with Wurster inserts.
Aptar Pharma Unveils its eDose Counter for MDIs at RDD Europe 2017
Aptar Pharma recently announced it will present its patented eDose Counter for Metered Dose Inhalers (MDIs) at the RDD Europe 2017 conference in Nice France, April 25-28, 2017.
Gattefossé Announces Inauguration of its North America Technical Center of Excellence
To expand its presence in the North American region, the Gattefossé Group announces the establishment of its fourth Technical Center of Excellence, located in Paramus, New Jersey.
MedCision Announces the ThawSTAR Early Adopter Program for Limited Time
MedCision, a leader in the automation of basic clinical processes, recently announced the ThawSTAR Cell Thawing Early Adopter Program for companies undergoing early cell therapy trials.
HealthFactors Announces Collaboration With Koronis Biomedical Technologies
HealthFactors, Inc. and Koronis Biomedical Technologies (KBT) recently announced a formal collaboration designed to improve healthcare and outcomes for people with respiratory conditions associated with asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.
Capsugel Expands Late-Stage Inhalation Product Development Capabilities
Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, today announced the expansion of its late-stage inhalation capabilities to advance dry powder inhalation (DPI) concepts through late-stage clinical trial and commercial production.
Aptar Pharma's Preservative-Free Multidose Dispenser Chosen for the First Time
Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the US prescription market for the first time with Allergan’s RESTASIS MULTIDOSE (Cyclosporine Ophthalmic Emulsion) 0.05%.
Nemera Wins Editor's Choice Category at INTERPHEX Awards for Safelia®
International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization and sponsored by the Parenteral Drug Association (PDA), recently announced the winners for the INTERPHEX Exhibitor Awards for 2017.
Alcami Introduces Seamless Customer Experience With New Customer Portal & Application, Alcami OnDemand™
Alcami is setting the industry standard for project management and transparency with its new Customer Portal and Mobile Application: Alcami OnDemand™. The initial phase will concentrate on the sample submission process within its Analytical Testing offering.
Pfizer CentreOne Adds Highly Potent Solid Oral Dose to its Service Portfolio
Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, recently announced that it has grown its service portfolio to include contract manufacturing of highly potent solid oral dose medicines.
ABITEC Corporation & IMCD Announce Specialty Lipid Distribution Agreement
US ingredients conglomerate announces new partnership to distribute specialty lipids into the pharmaceutical and nutritional markets in Asia and South America.
Avomeen Analytical Services Announces New CEO
Avomeen Analytical Services, a full-service independent analytical testing and product development laboratory based in Ann Arbor, MI, recently announced that Mark Harvill has been named its CEO. High Street Capital of Chicago and Avomeen founder and retiring CEO Shri Thanedar, PhD, made the announcement.
$100 Billion of Revenues up for Grabs for Drug Manufacturers by 2020 as Patents for Key Biologics Expire
Although complexities inherent in biological drug manufacturing are creating barriers for further expansion of the biosimilars market, imminent patent expiries of key biologics are set to create new opportunities for biosimilar manufacturers, according to business intelligence provider GBI Research.
Ompi EZ-Fill Becomes an Internationally Recognized Standard Platform for RTU Sterile Containers
Ompi, the company within Stevanato Group specialized in glass primary packaging for the pharmaceutical industry, has recently signed a license agreement with Gerresheimer.


Click here to see the showcases

RDD (Respiratory Drug Delivery)
April 25-28
Nice, France

Pre-filled Syringes East Coast
April 26-27
Boston, MA

AAPS National Biotechnology Meeting
May 1-3
San Diego, CA

Innovation Networking Summit & Table-top Exhibition
May 4-5
Hilton Hotel, Parsippany, NJ

CPhI North America & Informex
May 16-18
2017 Philadelphia, PA

Pre-filled Syringes West Coast
June 5th & 6th, San Diego, USA

July 6-7
London, United Kingdom 

BIO 2017

June 19 - 22
San Diego, CA

Controlled Release Society Meeting
July 16-19 Boston, MA

CPhI Worldwide
October 24-26
Frankfurt, Germany

Universe of Prefilled Syringes & Injection Devices Europe
November 7-8
Nienna, Austria

November 12-17
San Diego, CA


Copyright © 2017  Drug Development & Delivery All Rights Reserved. Privacy Policy / Terms and Conditions